Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,084 across all filing types
Latest filing 2023-07-21 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This document details shareholdings, positions, and dealings in the securities of 'Network International Holdings PLC' by 'Citadel Group'. Since this is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A (which usually refers to the corporate announcement of the deal itself) or Director's Dealing (which refers to company insiders), it is classified as a Regulatory Filing (RNS).
2023-07-21 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act when a person holds 1% or more of a company's relevant securities during an offer period. It details the discloser's (Citadel Group) interests, short positions, and dealings in the securities of the offeree (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for M&A activity and does not fit into other categories like general RNS or annual reports. Given the specific nature of the 'Form 8.3' disclosure regarding takeover rules, it is classified as a Major Shareholding Notification (MRQ) as it pertains to significant ownership and position changes during a takeover.
2023-07-21 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 96% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings of Citadel Group in the securities of Horizon Therapeutics PLC. This type of document is a mandatory regulatory disclosure regarding major shareholding interests and derivative positions during a takeover scenario. It does not fit into categories like 'Major Shareholding Notification' (which is usually for crossing specific percentage thresholds) or 'Director's Dealing' (which is for company insiders). Therefore, it is classified as a Regulatory Filing (RNS).
2023-07-20 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of 'NETWORK INTERNATIONAL HOLDINGS PLC'. Since this is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A (which usually refers to the corporate announcement of the deal itself) or Major Shareholding Notifications (which are typically TR-1 forms), it is best classified as a Regulatory Filing (RNS).
2023-07-20 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. Since it is a specific regulatory disclosure regarding share ownership and takeover activity that does not fit into the other categories like 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', it is best classified as a Regulatory Filing (RNS).
2023-07-19 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act for persons with interests in relevant securities representing 1% or more during a takeover. It details shareholdings, derivatives, and dealings in Horizon Therapeutics PLC by Citadel Group. As this is a specific regulatory disclosure regarding major shareholding and takeover-related positions, it falls under the 'Major Shareholding Notification' category.
2023-07-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.